Monday, May 12, 2025, 9:21 am
A new head‐to‐head study reveals that Eli Lilly’s obesity drug Zepbound significantly outperformed Novo Nordisk’s Wegovy, with patients losing nearly 50% more weight. The dramatic results have stirred both excitement and a few wry smiles among the medical community as the weight loss war intensifies.
People taking Eli Lilly's obesity drug, Zepbound, lost nearly 50 per cent more weight than those using rival Novo Nordisk's Wegovy.
Doctors recommend that a person’s waistline be no more than half their height
permalink / 2 stories from sources in 5 hours ago #business #nutrition #health #fitness
Following a recent electoral victory, Carney’s Liberal government faces pointed scrutiny after pledging 500,000 new homes. Critics and strategists alike are weighing in with strategic advice on effective government building, emphasizing the urgency of solid policy delivery amid sky‐high expectations. More...
A new study reveals that Ontario hospitals spent over $9 billion on for-profit nurse staffing agencies in a decade. The report, lamenting skyrocketing costs, has government and hospital boards reeling amid mounting concerns over fiscal sustainability. Hospitals appear to have found a costly shortcut that leaves taxpayers paying the price. More...
A judicial recount is in progress in a rural Newfoundland riding after an initial 12-vote Liberal lead stirred uncertainty. In this high-stakes electoral showdown, every ballot is scrutinized and the slim margin only underscores how pivotal each vote is in determining the final outcome. More...
Alberta Premier Danielle Smith’s administration has indefinitely frozen the industrial carbon price at $95 per tonne, choosing to keep heavy emitter costs flat despite rising environmental concerns. This bold move has sparked both support and skepticism among industry and environmentalists alike. More...
First Nations leaders have vocally condemned discussions around Alberta’s potential separation, decrying the move as an “irresponsible” affront to established treaties. The backlash centers on the lack of meaningful consultation with indigenous communities, raising constitutional alarms and reigniting heated debates on regional autonomy. More...
Trump’s new drug price order sparks industry outrage (6 hours ago)
Ontario Starbucks stores ratify first union contract, sparking labor momentum (22 hours ago)
Hudson’s Bay Assets Up for Grabs Amid Bidding Frenzy (2 days ago)
Toronto doctor loses licence amid multiple harassment charges (0 hours ago)
Montreal health officials report sharp rise in tuberculosis cases (0 hours ago)
Trump’s new drug price order sparks industry outrage (6 hours ago)
Disclaimer: The information provided on this website is intended for general informational purposes only. While we strive for accuracy, we do not guarantee the completeness or reliability of the content. Users are encouraged to verify all details independently. We accept no liability for errors, omissions, or any decisions made based on this information.